@article{AOI4733,
author = {Maxine Caws and Sarah Jane Dunstan and Buddha Basnyat},
title = {Xpert Ultra and TB meningitis: advancing towards policy revision?},
journal = {Annals of Infection},
volume = {2},
number = {0},
year = {2018},
keywords = {},
abstract = {Tuberculous meningitis (TBM) is a devastating condition with high mortality and survivors are often left with severe neurological sequelae. HIV-associated TBM can have mortality rates exceeding 60% (1). Early diagnosis and initiation of treatment is critical for survival. Unfortunately the diagnosis of TBM can be more of an art than a science, as a recent report in the Lancet by Bahr and colleagues highlights. There is currently no diagnostic test with high sensitivity and specificity.},
issn = {2616-2709}, url = {https://aoi.amegroups.org/article/view/4733}
}